[14C] Study to Investigate the Mass Balance and Biotransformation of WPV01 in Healthy Adult Chinese Male Participants

Inclusion Criteria: * Healthy adult males * Participants aged ≥18 years and ≤55 years old * Body weight: Body mass index (BMI) between 19.0 and 26.0 kg/m2 (including borderline values), body weight no less than 50.0 kg. * Voluntarily participate in the clinical trial and sign the informed consent * Able to communicate well with the investigator and able to complete the trial in accordance with the protocol Exclusion Criteria: * Participants who have abnormalities and clinical significance after comprehensive physical examination, vital signs, routine laboratory tests, thyroid function, chest CT, abdominal ultrasound, etc. * Participants whose 12-lead electrocardiogram test results show corrected QT interval ≥450 msec * Participants who is positive for Hepatitis B Surface Antigen, Hepatitis C Antibody, HIV Antibody and Syphilis Antibody * Participants who have used any drug that inhibits or induces hepatic drug metabolizing enzymes within 30 days prior to the screening period * Participants who have used any prescription medication, over-the-counter medication, herbal or dietary supplements, such as vitamins, calcium supplements, within 14 days prior to the screening period * Participants who have a history of any clinically serious disease or disease/condition that, in the opinion of the investigator, may affect the results of the test, including, but not limited to, a history of circulatory, respiratory, endocrine, neurological, gastrointestinal, urological, or hematologi…